Epilepsy Clinical Trials

Showing 741-760 of 803 trials

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

NCT01407523

To evaluate the safety of Levetiracetam IV 15-minute infusion administered every 12 hours as adjunctive treatment in subjects with Partial Onset Seizures after switching from the equivalent Levetiracetam oral dose.

EpilepsyPartial Onset Seizures

UCB Japan Co. Ltd.16 participantsStarted Jul 2011

Niigata, Niigata, Japan • Shizuoka, Shizuoka, Japan • Kodaira, Tokyo, Japan +1 more locations

COMPLETED

Lamotrigine Pregnancy Registry (LAM05)

NCT01064297

Antiepileptic drugs (AEDs) are not indicated for use in pregnancy. However, women with epilepsy, and other approved indications including bipolar disorder, may require or be unintentionally exposed to AEDs during pregnancy. Prior to an AED being marketed there are few data available on drug safety in pregnancy: data from animal models may not translate directly to humans and pregnant women are routinely excluded from clinical trials. The International Lamotrigine Pregnancy Registry was established by GlaxoSmithKline (GSK) in 1992 to monitor the safety of lamotrigine during pregnancy.

EpilepsyBipolar Disorder

GlaxoSmithKline3,416 participantsStarted Nov 2001

COMPLETEDPhase 2

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

NCT00210522

The purpose of this study is to evaluate the effectiveness and safety of the novel compound RWJ-333369 in reducing the frequency of seizures in patients with epilepsy.

EpilepsyEpilepsies, Partial

SK Life Science, Inc.421 participantsStarted May 2005

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Lamotrigine Pregnancy Registry (LAM05)

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Related Searches

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

A Pharmacogenomic Exploration of Lacosamide Response

Multimodal Imaging in Pre-surgical Evaluation of Epilepsy

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database

Prevention of Post-traumatic Seizures With Levetiracetam

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

Bipolar Disorder in Epilepsy

Putting Electroencephalography (EEG) in the Emergency Department

Scalp Nerve Blocks for Post-Craniotomy Pain

Coping Skills Training (CST) for Children With Chronic Health Conditions

Personalizing Health Outcome in Epilepsy Now - An Introduction to Clinical Services

The Effect of Music Periodicity on Interictal Epileptiform Discharges

EEG Objectification in Neuropsychiatry